Join to view full profile
1515 Holcombe BlvdHouston, TX 77030
Phone+1 713-792-6161
Fax+1 713-794-7733
Dr. Afsharkharghan is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Baylor College of MedicineFellowship, Hematology and Medical Oncology, 1997 - 2000- Baylor College of MedicineResidency, Internal Medicine, 1993 - 1997
Hacettepe University FOMClass of 1991
Certifications & Licensure
FL State Medical License 2021 - Present
AZ State Medical License 2023 - 2028
TN State Medical License 2023 - 2028
GA State Medical License 2024 - 2027
IN State Medical License 1997 - 2027
LA State Medical License 2023 - 2027
MS State Medical License 2024 - 2027
American Board of Internal Medicine Hematology- American Board of Internal Medicine Medical Oncology
- Join now to see all
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification ClinicStation, UT MD Anderson Cancer Center, 2013-2015
Publications & Presentations
PubMed
- 8 citationsAssociation between abnormal lipid profile and inflammation and progression of myelodysplastic syndrome to acute leukemia.Wei Qiao, Elliana Young, Chun Feng, Suyu Liu, Jeff Jin
Experimental Hematology & Oncology. 2022-09-16 - 14 citationsNovel Markers for Liquid Biopsies in Cancer Management: Circulating Platelets and Extracellular Vesicles.Sara Corvigno, Anna Maria Johnson, Kwong-Kwok Wong, Min Soon Cho, Vahid Afshar-Kharghan
Molecular Cancer Therapeutics. 2022-07-05 - 21 citationsPlatelets Increase the Expression of PD-L1 in Ovarian Cancer.Min Soon Cho, Hani Lee, Ricardo Gonzalez-Delgado, Dan Li, Tomoyuki Sasano
Cancers. 2022-05-19
Grant Support
- Novel Biomarkers Predicting Blood Clots in Ovarian CancerUNIVERSITY OF TX MD ANDERSON CAN CTR2023–2028
- Novel Biomarkers Predicting Blood Clots in Ovarian CancerUNIVERSITY OF TX MD ANDERSON CAN CTR2023–2028
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
